Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Not applicable Interventional

Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial

ClinicalTrials.gov ID: NCT06863129

Public ClinicalTrials.gov record NCT06863129. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 28, 2026, 4:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical trial is to find out if removing and replacing part of the hip bone works better than using metal hardware to stabilize the bone in patients whose cancer has spread to the hip. The main questions are: 1. Does removing and replacing part of the bone work better than just stabilizing it with metal hardware? 2. Does removing and replacing the bone help reduce problems like cancer coming back or the metal hardware breaking? Researchers will compare two treatments: using metal rods and plates to stabilize the bone (internal fixation) versus removing part of the bone and possibly replacing the hip joint (resection and reconstruction) to see if the second option causes fewer problems. Participants will: * Be randomly assigned to one of two groups (internal fixation or resection and reconstruction). * Have one of the two surgeries based on which group they're in. * Go to follow-up appointments with the study doctor at 2 weeks, 6 weeks, 4 months, 6 months, 9 months, and 12 months after surgery.

Study identification

NCT ID
NCT06863129
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Michelle Ghert, MD
Other
Enrollment
334 participants

Conditions and interventions

Interventions

Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2025
Primary completion
May 31, 2029
Completion
May 31, 2030
Last update posted
Jul 7, 2026

2025 – 2030

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
University of Colorado Hospital Aurora Colorado 80045 Recruiting
Parkview Packnett Family Cancer Institute Fort Wayne Indiana 46845 Recruiting
University of Maryland Medical Center Baltimore Maryland 21201 Active, not recruiting
Albany Medical Center Albany New York 12206 Active, not recruiting
University of Cincinnati Medical Center Cincinnati Ohio 45219 Recruiting
Good Samaritan Regional Medical Center Corvallis Oregon 97330 Withdrawn
Oregon Health and Science University Hospital Portland Oregon 97239 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

Recently updated Metastatic Bone Disease trials

Other public records listing Metastatic Bone Disease. Sorted by last update posted; newest first. Not a recommendation.

All Metastatic Bone Disease trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06863129, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2026 · Synced Jul 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06863129 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →